# Plandai Biotechnology, Inc.

Plandai Biotechnology, Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Plandai Biotechnology, Inc.
- **Former names in filing history:** Diamond Ranch Foods, Ltd., NEW (2005-03-16 to 2012-01-09)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Fiscal year end:** June 30
- **SEC CIK:** 0001317880

## About

Plandai Biotechnology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001317880, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2016-06-30, it reported annual revenue of USD 92,898; net income of USD -10,072,344; total assets of USD 8,504,581 for the fiscal period ended 2015-06-30. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2015 (period ended 2015-06-30)

- **Revenue:** $92,898 (USD 92,898)
- **Net income:** -$10.1M (USD -10,072,344)
- **Total assets:** $8.5M (USD 8,504,581)
- **Cash and equivalents:** $33,619 (USD 33,619)
- **Operating cash flow:** -$2.7M (USD -2,703,939)

### FY2014 (period ended 2014-06-30)

- **Revenue:** $265,748 (USD 265,748)
- **Net income:** -$15.5M (USD -15,533,819)
- **Total assets:** $9.7M (USD 9,683,415)
- **Cash and equivalents:** $156,570 (USD 156,570)
- **Operating cash flow:** -$2.6M (USD -2,593,156)
- **Later filings:** Net income, Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2013 (period ended 2013-06-30)

- **Revenue:** $359,143 (USD 359,143)
- **Net income:** -$3.0M (USD -2,968,236)
- **Total assets:** $8.8M (USD 8,835,482)
- **Cash and equivalents:** $498,917 (USD 498,917)
- **Operating cash flow:** -$1.8M (USD -1,776,736)
- **Later filings:** Net income, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2012 (period ended 2012-06-30)

- **Net income:** -$3.8M (USD -3,774,307)
- **Total assets:** $6.1M (USD 6,057,007)
- **Cash and equivalents:** $5,112 (USD 5,112)
- **Operating cash flow:** -$796,296 (USD -796,296)
- **Later filings:** Net income: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 10-Q — filed 2023-03-20 — period 2016-09-30 — 10-Q
- Form 10-K — filed 2023-03-16 — period 2016-06-30 — 10-K
- Form SC 13G — filed 2021-01-21 — SCHEDULE 13G
- Form SC 13G — filed 2018-02-14
- Form SC 13G — filed 2016-09-27 — SC 13G
- Form 8-K — filed 2016-09-21 — period 2016-09-15 — FORM 8-K
- Form SC 13G — filed 2016-09-01 — SCHEDULE 13G
- Form 10-Q — filed 2016-08-17 — period 2016-03-31 — FORM 10-Q
- Form 10-Q — filed 2016-08-12 — period 2015-12-31 — FORM 10-Q
- Form 10-Q — filed 2016-07-29 — period 2015-09-30 — FORM 10-Q
- Form 10-K — filed 2016-06-30 — period 2015-06-30 — FORM 10-K
- Form 8-K — filed 2016-04-27 — period 2016-04-20 — FORM 8-K

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/plandai-biotechnology-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology